CEVA Animal Health is the world’s ninth-largest veterinary pharmaceutical group and has been the subject of several leveraged buy-outs (LBOs). Sorgem Evaluation is the independent expert tasked with carrying out a valuation of the Group and providing an opinion on the value of several categories of shares held by the staff share scheme (FCPE).
Actualités
Proposed public withdrawal offer by the SMABTP Group for Société de la Tour Eiffel at a price of 8.20 euros
2 April 2026
Lire
Actualités
In its judgement of 2 April 2025 (Case No. RG 23/05696), the Paris Court of Appeal held that EMMA was
10 April 2025
Lire
Actualités
Sorgem Evaluation recently assisted a client who, as part of its derivatives business, needed to switch to the Euronext clearing
10 March 2025
Lire
contact us
